Maze Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized for Q1 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Maze Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate for Q1 2025.
  • Maze Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending February 28, 2025 was 10M shares.
Preferred Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 10M Feb 28, 2025 10-Q 2025-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.